Andrea MS - Tabula Rasa Co Officer
Insider
Andrea MS is Co Officer of Tabula Rasa HealthCare
Age | 42 |
Phone | 866 648 2767 |
Web | https://www.tabularasahealthcare.com |
Tabula Rasa Management Efficiency
The company has return on total asset (ROA) of (0.0598) % which means that it has lost $0.0598 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.552) %, meaning that it created substantial loss on money invested by shareholders. Tabula Rasa's management efficiency ratios could be used to measure how well Tabula Rasa manages its routine affairs as well as how well it operates its assets and liabilities.Tabula Rasa HealthCare currently holds 336.13 M in liabilities. Tabula Rasa HealthCare has a current ratio of 1.7, which is within standard range for the sector. Note, when we think about Tabula Rasa's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Scott Oberlink | Definitive Healthcare Corp | N/A | |
Joseph Mirisola | Definitive Healthcare Corp | 40 | |
CPA CPA | National Research Corp | 66 | |
Michael Vesey | Forian Inc | 62 | |
Jon Maack | Definitive Healthcare Corp | N/A | |
Gregory MS | National Research Corp | N/A | |
Donald Vick | Streamline Health Solutions | 61 | |
Andrew Douglas | Forian Inc | N/A | |
Adam Dublin | Forian Inc | 59 | |
Jawad Shaikh | Streamline Health Solutions | N/A | |
David Terrell | Forian Inc | N/A | |
Tom Penque | Definitive Healthcare Corp | N/A | |
Amy Sebero | Streamline Health Solutions | N/A | |
Justin Steinman | Definitive Healthcare Corp | N/A | |
Jon Boumstein | National Research Corp | N/A | |
Daniel Barton | Forian Inc | 59 | |
Wendy Lucio | Streamline Health Solutions | N/A | |
Richard Booth | Definitive Healthcare Corp | 55 | |
David Kronfeld | Definitive Healthcare Corp | N/A | |
Robert JD | Definitive Healthcare Corp | 54 | |
Jona Raasch | National Research Corp | 65 |
Management Performance
Return On Equity | -5.55 | |||
Return On Asset | -0.0598 |
Tabula Rasa HealthCare Leadership Team
Elected by the shareholders, the Tabula Rasa's board of directors comprises two types of representatives: Tabula Rasa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tabula. The board's role is to monitor Tabula Rasa's management team and ensure that shareholders' interests are well served. Tabula Rasa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tabula Rasa's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian Adams, Pres CEO | ||
Michael Greenhalgh, Chief Officer | ||
Bob MS, Chief Officer | ||
CPA CFA, Chief Officer | ||
Jacques BPharm, RD Pharmacotherapy | ||
Kathleen MBA, Chief Officer | ||
Andrea MS, Co Officer | ||
Phillip MS, Chief Officer | ||
JD DMIN, G Counsel |
Tabula Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tabula Rasa a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -5.55 | |||
Return On Asset | -0.0598 | |||
Profit Margin | (0.28) % | |||
Operating Margin | (0.06) % | |||
Current Valuation | 548.09 M | |||
Shares Outstanding | 27.05 M | |||
Shares Owned By Insiders | 12.09 % | |||
Shares Owned By Institutions | 70.69 % | |||
Number Of Shares Shorted | 732.92 K | |||
Price To Earning | 67.61 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |